FEops Elects Tom Fleming to its Board of Directors

Ghent, Belgium: 15 February 2018 - FEops, a leader in personalized computational modelling and simulation for structural heart interventions, today announced that it has elected Tom Fleming to its board of directors, effective immediately. In his most recent role, Fleming served for over five years as Vice President and General Manager for Boston Scientific Corporation in the Structural Heart Valve business. He has been active in the cardiovascular device market for more than two decades.

More info on FEops' website.


Next > Mainstay Medical publishes 2017 full year results

Previous > New England Biolabs and Bluebee partner to deliver an end-to-end data analysis solution for NEBNext direct target enrichment